Journal of Controlled Release

Article	Citations
Inside Back Cover	597
Outside Back Cover	476
Impact of interferon-γ on the target cell tropism of nanoparticles	442
Cavitation-assisted sonothrombolysis by asymmetrical nanostars for accelerated thrombolysis	441
Corrigendum to “Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch” [Journal of Controlled Release 372 (2024) 304–317]	375
Outside Back Cover	349
Outside Front Cover: Yisheng Peng et al	324
Transdermal carbon monoxide delivery	306
Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model	300
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors	283
Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy	271
Enhanced browning of adipose tissue by mirabegron-microspheres	263
Single-cell RNA transcriptome landscape of murine liver following systemic administration of mesoporous silica nanoparticles	213
In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy	212
Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence	212
The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model	209
Full-cycle study on developing a novel structured micromixer and evaluating the nanoparticle products as mRNA delivery carriers	208
An efficient (nano) silica - In glucan particles protein encapsulation approach for improved thermal stability	206
Mitochondria-targeted hybrid nanovesicles trigger immunogenic cell death and remodel tumor neutrophils for enhanced colorectal cancer immunotherapy	205
Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel	204
Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy	203
Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention	201
Lanthanide nanocrystals-based direct triple-state energy converters for mitophagy and ferroptosis-induced antitumor immunoreaction	192
Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3	186
Collagenase-modified polydopamine nanoparticles for safe and effective vitreolysis	181

Outside Front Cover	178
Outside Front Cover - K. Keiichiro et al	173
Inside Front Cover - J. Xiaohong et al.	169
Targeted and quantitatively modeled biologic delivery via dual-functional probiotic yeast in inflammatory bowel disease	167
Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis	159
Multifunctional nanoparticles potentiate in-situ tumor vaccines via reversing insufficient Photothermal therapy by disrupting tumor vasculature	158
Identification of functional biomarkers for personalized nanomedicine in advanced breast cancer in vitro models	158
Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases	154
Self-sacrificing templated-derived chitosan microcapsules for targeted drug delivery in thrombolytic therapy	152
Oscillation-generating micromixing (FDmiX) – a new method for manufacturing of mRNA-lipid nanoparticles with scalable high-throughput production	149
Content list including Graphcal Abstracts	147
Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model	146
Losartan primes pancreatic tumors for effective exosome-biomimetic chemo-immunotherapy	146
Boronate-crosslinked hydrogel enables localized chemoimmunotherapy to remodel the immune microenvironment in triple-negative breast cancer	142
Polymer selection in amorphous solid dispersions: From stabilization mechanisms to marketed drug products	141
Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis	139
Intraneural delivery of CBD3A6K-RhB via PEG-PLGA nanoparticles for neuropathic pain therapy	136
Buforin IIb and bilirubin co-loaded CeO₂nanoparticles mitigate sepsis-related encephalopathy via synergistic anti-inflammation and neuroprotection	133
Dual-stimulus phototherapeutic nanogel for triggering pyroptosis to promote cancer immunotherapy	133
Nanobubble based sonobiopsy reveals circulating protein signatures of BBB opening in healthy and glioblastoma-bearing mice	129
Biomaterial scaffolds for therapeutic immune cell engineering and delivery	129
Oxygen-boosted fluorinated prodrug hybrid nanoassemblies for bidirectional amplification of breast cancer ferroptosis	129
Nanogel-controlled delivery of caerin peptides enables sustained intratumoural retention and immunometabolic reprogramming	129
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?	127
Multifunctional amino acid-based nanoparticles for sequential drug delivery to overcome multidrug resistant cancer	127
Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer	126
Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization	125
Thiourea-modified poly(l-lysine) carriers with multiple hydrogen bonding interactions for safe and robust mRNA vaccine therapy	125
Multifunctional delivery strategies and nanoplatforms of SN-38 in cancer therapeutics	120
Dynamic versus static testing and in vivo mechanical performance of poly(glycolide-trimethylene carbonate-ε-caprolactone) delayed release implants	120
Orthogonal upconversion nanocarriers for combined photodynamic therapy and precisely triggered gene silencing in combating keloids	119
Nanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability	118
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma	118
Customization of protein corona to reprogram cancer nanomedicines: Mechanistic insights and therapeutic implications	116
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment	116
Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug	114
Metal-phenolic network-based polymeric nanocarriers facilitating antibody cytoplasmic delivery and anti-tumor effects to orthotopic breast tumors	113
Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients	112
Autophagy-activating aluminum hydroxide nanovaccine for enhanced antigen presentation and anti-tumor immunity	112
Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy	111
Extracellular vesicles for renal therapeutics: State of the art and future perspective	111
IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation	111
A superoxide anion-responsive persulfide prodrug for remedying dry eye disease	111
Ultrasound-activatable nanovaccines amplify dual-modal ROS for cancer sono-immunotherapy	111
Healing with precision: A multi-functional hydrogel-bioactive glass dressing boosts infected wound recovery and enhances neurogenesis in the wound bed	110
Combinatorial physical methods for cellular therapy: Towards the future of cellular analysis?	110
Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy	109
Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy	108
Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy	107
Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response	105

An engineered dual function peptide to repair fractured bones	104
Surface-engineered mesenchymal stem cell for refractory asthma therapy: Reversing airway remodeling	104
Oral mucosal vaccination using integrated fiber microneedles	103
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair	101
Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies	100
mRNA therapeutics: Molecular mechanisms, delivery platforms, regulatory frameworks, and equitable global access	100
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine	98
Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease	98
Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice	98
Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications	97
Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy	97
The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules	96
Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma	96
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment	95
In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer	95
Melittin-incorporated nanomedicines for enhanced cancer immunotherapy	93
Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models	93
Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy	93
Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination	93
Corrigendum to “The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs” [J. Control. Release 345 (2022) 819–831]	93
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin	92
Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles	92
Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment	91
Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies	91
Mechanism exploration of intestinal mucus penetration of nano-Se: regulated by polysaccharides with different functional groups and molecular weights	91
A next-generation STING agonist MSA-2: From mechanism to application	90
ZIF-8-modified hydrogel sequentially delivers angiogenic and osteogenic growth factors to accelerate vascularized bone regeneration	90
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome	89
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation	89
Self-assembly hydrogels of therapeutic agents for local drug delivery	89
Hybrid prodrug nanoassembly for hypoxia-triggered immunogenic chemotherapy and immune modulation	89
Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury	88
Inside front cover: Yufan Qian et al	88
MSC-derived extracellular vesicles as nanotherapeutics for promoting aged liver regeneration	88
Editorial Board	88
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction	88
Modulation of GABAergic neurons in acute epilepsy using sonogenetics	87
Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease	87
Thermal/ultrasound-triggered release of liposomes loaded with Ganoderma applanatum polysaccharide from microbubbles for enhanced tumour ablation	87
Inside Front Cover	86
Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells	85
Corrigendum to “Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision” [Journal of Controlled Release, Volume 379, 10 March 2025, Pages 12	85
Outside Back Cover: Yujie Wang et al	85
Outside Front Cover	85
Inside Back Cover	84
Outside Front Cover	84
Inorganic nanomaterials for drug delivery and therapeutic applications: Promise, pitfalls, and publication standards in Journal of Controlled Release	83
Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges	83
Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels	83
Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection	83
Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor	83
Outside Front Cover	83
An “IgG-hitchhiking” approach for rapid tumor accumulation and clearance of photosensitizers	82
In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy	82
Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes	82
Corrigendum to “Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy” [Journal of Controlled Release 353 (2023) 447–461]	82
Remote loading of an autoantigen in PLGA nanoparticles for the treatment of multiple sclerosis	82
Orthogonal and complementary measurements of properties of drug products containing nanomaterials	81
Chelator-guided radiosynthesis, preclinical evaluation, and clinical study of [68Ga]Ga-TRAP-(FAPI)3 for positron emission tomography imaging of tumors	81
Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential	81
Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes	81
An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapy	80
Monitoring pH-induced lipid dynamics in mRNA-lipid nanoparticles by synchrotron small-angle X-ray scattering	80
Structure-guided design and clinical evaluation of 68Ga-GP01 for FAP-targeted PET imaging in solid tumors	80
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer	80
Redox-active microneedles for disease management	79
A hydrogen generator enhances immunogenic transarterial chemoembolization in hepatocellular carcinoma	79
Multimodal nanoparticles co-delivering bevacizumab and dichloroacetate for dual targeting of neoangiogenesis and hyperglycolysis in glioblastoma treatment	79
An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis	79
Restoring tumor antigenicity activates the “bystander” T cell immune cycle	79
Engineered extracellular vesicles platforms: translational considerations	78
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates	78
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections	78
Editorial Board	77
Squid tentacle-mimetic magnetically targeted nanomotors to overcome the bladder barrier for synergistic chemotherapy-immunotherapy of bladder cancer	76
Strengthening scientific credibility in the face of misinformation and disinformation: Viable solutions	76
The use of Xenon magnetic lipid bubbles to detect and treat intermittent hypoxia-induced cognitive impairment	76
A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy	75
Dual-targeted molybdenum nanomedicine treats acute pancreatitis by blocking mitochondrial DNA-triggered cGAS-STING signaling via ROS modulation	75
Acetyl-lysine human serum albumin nanoparticles activate CD44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication	75

Nanodrugs based on co-delivery strategies to combat cisplatin resistance	75
Dissolving microneedle co-deliver mitochondria-targeted Nanozyme and Tofacitinib for synergistic treatment of Rosacea	75
Protein-based delivery systems for RNA delivery	74
Nebulized inhalation of LPAE-HDAC10 inhibits acetylation-mediated ROS/NF-κB pathway for silicosis treatment	74
Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route	74
Engineering immune cells for next-generation therapies	74
Sequential gemcitabine and panobinostat-loaded albumin nanoparticle delivery via thermosensitive hydrogel in pancreatic peritoneal metastasis	73
Fusobacterium nucleatum-targeted polymeric micelles disrupting biofilm-immune crosstalk for precision colorectal cancer immunotherapy	73
Large and low-PEG lipid nanoparticles enable efficient dendritic cell targeting for potent mRNA Cancer vaccines	73
A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicity	73
Photothermal-controlled NO-releasing Nanogels reverse epithelial-mesenchymal transition and restore immune surveillance against cancer metastasis	73
Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing	72
Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke	71
Controlled release of manganese and magnesium ions by microsphere-encapsulated hydrogel enhances cancer immunotherapy	71
Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine	71
Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment	70
Harnessing the GSDME–GSDMD pyroptosis cascade to turn tumour cells into “high-energy bombs” via disulfidptosis for potent lung cancer immunotherapy	70
A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy	70
Zeolite imidazolate framework-8 in bone regeneration: A systematic review	70
Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules	70
Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer	70
Hyperglycemia-responsive nitric oxide-releasing biohybrid cryogels with cascade enzyme catalysis for enhanced healing of infected diabetic wounds	69
Ultrasound-activated biomimetic nanobubbles achieve synergistic immunotherapy by tumor cell membrane-based vaccination and PD-L1 PROTAC degradation	69
Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles	69
Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells	68
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity	67
Engineering the subcutaneous delivery of antibody-drug conjugates	67
Clinically relevant dosing of miR-145 micelles curbs atherosclerosis in vivo	67
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges	67
COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice	67
Nanoparticle-mediated synergistic disruption of tumor innervation and redox homeostasis for potent antineoplastic therapy	67
Unleashing the power of nucleic acid therapeutics through efficient cytosolic delivery	67
Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions	67
A preparation method for mRNA-LNPs with improved properties	67
Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice	66
Programmable hierarchical hydrogel dressing for sequential release of growth factor and DNase to accelerate diabetic wound healing	66
Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives	66
Engineered bacterial extracellular vesicles for central nervous system diseases	66
Size matters: Altering antigen specific immune tolerance by tuning size of particles	66
In situ forming silk fibroin hydrogel dressing accelerates acute wound healing via immunomodulation and extracellular matrix regeneration	66
Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis	66
Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer	66
Highly flexible antibiotic implants for root canal treatment	66
Non-invasive administration of exosomes	66
Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer	66
Substrate-free dissolving microneedles with barbed shape to increase adhesion and drug-delivery efficiency to skin	66
In situ enrichment and delivery of STING agonists by protamine-modified Salmonella for cancer immunotherapy	66
Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics	66
Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging	66
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening	66
Bioengineered nanotechnology for nucleic acid delivery	65
cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer	65
Strategies of tea polyphenol-mediated delivery systems based on Mannich reaction for precision nutrition	65
Dual-corn-derived nanofiber membrane for subconjunctival injury: Sequential release of dual-natural products for programmed anti-inflammation and anti-fibrosis	65
Apoptotic-body-inspired nanoplatform targeting the lung-macrophage-mitochondrial axis for acute lung injury therapy	65
Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II	65
A combination nano-immunotherapy targeting cholesterol crystals and STING signaling enhanced disruption atherosclerotic plaque pathogenesis	65
Strategic aspects for the commercialization of nanomedicines	65
CD40 agonistic-monovalent streptavidin fusion antibody for targeted neoantigen peptide delivery and potent cancer vaccination	65
Nanoparticle-mediated intracellular delivery of biomolecules to plants: From mechanistic insights to translational challenges	65
Protein-based nanocages for vaccine development	64
Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer	64
Macrophage membrane-biomimetic DNA nanocages deliver taurine to reprogram trained immunity for periodontitis therapy	64
Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression	64
Self-assembled Cu-alendronate nanoneedle sonozymes promoting infected bone regeneration via synergistic sonodynamic and chemodynamic therapy	64
Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs	64
Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds	64
Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats	63
In situ vaccine “seeds” for enhancing cancer immunotherapy by exploiting apoptosis-associated morphological changes	63
Editorial Board	63
Editorial Board	63
Outside Front Cover	63
Corrigendum to “Ultrasound-responsive polymersomes capable of endosomal escape for efficient cancer therapy” [Journal of Controlled Release 322 (2020) 81–94]	62
Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models	62
Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy	62
Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response	62
Determining topical product bioequivalence with stimulated Raman scattering microscopy	61
Content list including Graphcal Abstracts	61
Fluorescent Probes Targeting Acyl-CoA Synthetase Long-Chain Family Member 4 for Intraoperative Imaging of Hepatocellular Carcinoma	61
Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer	61
Hierarchically structured hydrogel exhibiting spatiotemporal release profiles: Enabling digital remote diagnosis and personalized therapeutics	61
Stabilizing liquid-like drug-rich intermediates by bile salts to suppress phase transformation and promote rapid absorption of cocrystals	60
Transdermal delivery and formulation design of opioids: Where are we now and where are we heading?	60
ROS-responsive nanodiscs for STING-NF-κB pathway inhibition and glycosaminoglycan layer restoration in interstitial cystitis/bladder pain syndrome therapy	60
A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy	60
Construction of novel magnetic systems for cancer immunotherapy via cancer-immunity cycle circuits	59
A cascade-regulated nanoadjuvant for antigen oxidation and capture to potentiate in-situ cancer vaccination	59
Fine-tuning of liposome integrity for differentiated transcytosis and enhanced antitumor efficacy	59
Corrigendum to “Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery” [Journal of Controlled Release	59
Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy	59
Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles	59
In memoriam: Professor Rimona Margalit (1941–2024)	59
Cardiosplenic axis-targeted immunomodulatory liposome for myocardial ischemia-reperfusion injury treatment	59
Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer	59
Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency	59